Alzheimer's disease drug development pipeline: 2019

2019741 citationsJournal Articlegold Open Access

Authors

Marwan N. Sabbagh · Lou Ruvo Brain Institute

Abstract

Drug development continues robustly at all phases despite setbacks in several programs in the recent past. Continuing unmet needs require a commitment to growing and accelerating the pipeline.

Topics & Keywords

Computational Drug Discovery Methods Health Systems, Economic Evaluations, Quality of Life Cholinesterase and Neurodegenerative Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alzheimer s & Dementia Translational Research & Clinical Interventions

Volume 5, Issue 1, pp. 272-293

DOI: 10.1016/j.trci.2019.05.008

Field-Weighted Citation Impact: 104.69